Neuronetics STIM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 48.5%-23.8pp | 72.3%-0.1pp | 72.5%-3.8pp | 76.3%-2.7pp | |
| Operating margin | -21.1%+25.1pp | -46.2%-3.3pp | -42.8%+11.0pp | -53.8%-4.0pp | |
| Net margin | -26.1%+32.2pp | -58.4%-16.1pp | -42.3%+14.7pp | -57%-0.6pp | |
| Returns | |||||
| Return on equity | -155.7%-14.5pp | -141.2%-75.1pp | -66.2%-13.9pp | -52.3%+4.1pp | |
| Return on invested capital | -35.6%+18.0pp | -53.6%+42.7pp | -96.3%+26.8pp | -123.1%-1.8pp | |
| Efficiency | |||||
| Asset turnover | 1.1×+0.5× | 0.6×0.0× | 0.6×+0.1× | 0.5×0.0× | |
| Liquidity | |||||
| Current ratio | 2×+0.2× | 1.9×-2.9× | 4.7×+1.8× | 3×-4.4× | |
| Leverage | |||||
| Debt-to-equity | 4×+1.1× | 3×+1.2× | 1.8×+1.1× | 0.7×+0.2× | |
| Per Share | |||||
| Book value per share | $0.34-61.1% | $0.87-26.8% | $1.19-43.8% | $2.12-36.5% | |
| Valuation | |||||
| Market capitalization | $90.46M-59.6% | $89.6M+6.4% | $84.24M-54.9% | $186.91M+58.9% | |
| Price / sales | 0.6×-1.4× | 1.2×0.0× | 1.2×-1.7× | 2.9×+0.7× | |
| Price / book | 6.8×-1.4× | 3.2×+0.8× | 2.5×-0.8× | 3.3×+1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuronetics's profit margins?
- Neuronetics (STIM) runs a 48.0% gross margin and a -19.4% operating margin, with a -24.5% net margin.
- Where do Neuronetics's ratios come from?
- Every ratio is computed from Neuronetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
